278 related articles for article (PubMed ID: 22793854)
1. Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.
Best SR; Niparko KJ; Pai SI
Otolaryngol Clin North Am; 2012 Aug; 45(4):807-22. PubMed ID: 22793854
[TBL] [Abstract][Full Text] [Related]
2. Manifestations of Human Papillomavirus in the Head and Neck.
Dable C; Nicolli E
Med Clin North Am; 2021 Sep; 105(5):849-858. PubMed ID: 34391538
[TBL] [Abstract][Full Text] [Related]
3. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Berman TA; Schiller JT
Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
6. Perspectives for the development of human papillomavirus vaccines and immunotherapy.
Bermúdez-Humarán LG; Langella P
Expert Rev Vaccines; 2010 Jan; 9(1):35-44. PubMed ID: 20021304
[TBL] [Abstract][Full Text] [Related]
7. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
Yang A; Farmer E; Lin J; Wu TC; Hung CF
Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
[TBL] [Abstract][Full Text] [Related]
8. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
Mehra R; Ang KK; Burtness B
Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
[TBL] [Abstract][Full Text] [Related]
9. AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus.
Guo T; Goldenberg D; Fakhry C
Head Neck; 2017 May; 39(5):833-839. PubMed ID: 28263449
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.
Cheng MA; Farmer E; Huang C; Lin J; Hung CF; Wu TC
Hum Gene Ther; 2018 Sep; 29(9):971-996. PubMed ID: 29316817
[TBL] [Abstract][Full Text] [Related]
11. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.
Guo T; Eisele DW; Fakhry C
Cancer; 2016 Aug; 122(15):2313-23. PubMed ID: 27152637
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus in head and neck cancers: biology, prognosis, hope of treatment, and vaccines.
Psyrri A; Boutati E; Karageorgopoulou S
Anticancer Drugs; 2011 Aug; 22(7):586-90. PubMed ID: 21403517
[TBL] [Abstract][Full Text] [Related]
13. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
14. The role of human papillomavirus infection in head and neck cancers.
Syrjänen S
Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622
[TBL] [Abstract][Full Text] [Related]
15. Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire.
Anderson S; Isaac A; Jeffery CC; Robinson JL; Isaac DM; Korownyk C; Biron VL; Seikaly H
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):61. PubMed ID: 29073940
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects.
Vonsky MS; Runov AL; Gordeychuk IV; Isaguliants MG
Biochemistry (Mosc); 2019 Jul; 84(7):800-816. PubMed ID: 31509730
[TBL] [Abstract][Full Text] [Related]
17. Human Papillomavirus Induced Cervical and Oropharyngeal Cancers: From Mechanisms to Potential Immuno-therapeutic Strategies.
Saeed M; Faisal SM; Akhtar F; Ahmad S; Alreshidi MM; Kausar MA; Kazmi S; Saeed A; Adnan M; Ashraf GM
Curr Drug Metab; 2020; 21(3):167-177. PubMed ID: 32316888
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic HPV DNA vaccines.
Lin K; Roosinovich E; Ma B; Hung CF; Wu TC
Immunol Res; 2010 Jul; 47(1-3):86-112. PubMed ID: 20066511
[TBL] [Abstract][Full Text] [Related]
19. HPV as a model for the development of prophylactic and therapeutic cancer vaccines.
Samara RN; Khleif SN
Curr Mol Med; 2009 Aug; 9(6):766-73. PubMed ID: 19689303
[TBL] [Abstract][Full Text] [Related]
20. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]